CVE-2025-0970

Zenvia Movidesk Login redirect

Description

A vulnerability was found in Zenvia Movidesk up to 25.01.22. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file /Account/Login. The manipulation of the argument ReturnUrl leads to open redirect. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 25.01.22.245a473c54 is able to address this issue. It is recommended to upgrade the affected component.

Category

6.9
CVSS
Severity: Medium
CVSS 4.0 •
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.04%
Third-Party Advisory vuldb.com
Affected: Zenvia Movidesk
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.294361 vdb entry technical description
https://vuldb.com/?ctiid.294361 signature permissions required
https://vuldb.com/?submit.485985 third party advisory

Frequently Asked Questions

What is the severity of CVE-2025-0970?
CVE-2025-0970 has been scored as a medium severity vulnerability.
How to fix CVE-2025-0970?
To fix CVE-2025-0970, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-0970 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-0970 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-0970?
CVE-2025-0970 affects Zenvia Movidesk.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.